Narrow search
Showing 1 - 10 of 10,562
Cover Image
Patents, innovation, and the welfare effects of Medicare Part D
Gailey, Adam; Lakdawalla, Darius; Sood, Neeraj - In: Pharmaceutical markets and insurance worldwide, (pp. 317-344). 2010
Persistent link: https://www.econbiz.de/10008648651
Cover Image
Do cost-sharing and entry deregulation curb pharmaceutical innovation?
Grossmann, Volker - In: Journal of health economics 32 (2013) 5, pp. 881-894
Persistent link: https://www.econbiz.de/10010210741
Cover Image
The new Dutch health insurance system and its implications for pharmaceutical innovation
Cohen, Joshua - In: International journal of pharmaceutical and healthcare … 1 (2007) 3, pp. 214-225
Persistent link: https://www.econbiz.de/10003937254
Cover Image
Public health insurance and pharmaceutical innovation : evidence from China
Zhang, Xuan; Nie, Huihua - In: Journal of development economics 148 (2021), pp. 1-27
Persistent link: https://www.econbiz.de/10012658986
Cover Image
U.S. pharmaceutical markets : expenditures, health insurance, new products and generic prescribing from 1960 to 2016
Lu, Z. John; Comanor, William S.; Cherkas, Elliot; … - In: International journal of the economics of business 27 (2020) 1, pp. 1-26
Persistent link: https://www.econbiz.de/10012182277
Cover Image
Patient welfare and patient compliance : an empirical framework for measuring the benefits from pharmaceutical innovation
Ellickson, Paul; Stern, Scott; Trajtenberg, Manuel - In: Medical care output and productivity, (pp. 539-560). 2001
Persistent link: https://www.econbiz.de/10001619496
Cover Image
Patient welfare and patient compliance : an empirical framework for measuring the benefits from pharmaceutical innovation
Ellickson, Paul; Stern, Scott; Trajtenberg, Manuel - 1999
Persistent link: https://www.econbiz.de/10001355791
Cover Image
Patient Welfare and Patient Compliance : An Empirical Framework for Measuring the Benefits from Pharmaceutical Innovation
Ellickson, Paul - 1999
The main goal of this paper is to develop an empirical framework for evaluating the patient welfare benefits arising from pharmaceutical innovation. Extending previous studies of the welfare benefits from innovation (Trajtenberg, 1990; Hausman, 1996), this paper unpacks the separate choices made by...
Persistent link: https://www.econbiz.de/10012471921
Cover Image
Patient Welfare and Patient Compliance : an Empirical Framework for Measuring the Benefits from Pharmaceutical Innovation
Ellickson, Paul B.; Stern, Scott; Trajtenberg, Manuel - 2021
The main goal of this paper is to develop an empirical framework for evaluating the patient welfare benefits arising from pharmaceutical innovation. Extending previous studies of the welfare benefits from innovation (Trajtenberg, 1990; Hausman, 1996), this paper unpacks the separate choices made by...
Persistent link: https://www.econbiz.de/10013230589
Cover Image
Venture capital and asymmetric information in an evolutionary framework
Schertler, Andrea - 1999
Persistent link: https://www.econbiz.de/10013261049